US OptionsDetailed Quotes
INGN250117P25000
- 0.00
- 0.000.00%
15min DelayTrading Jan 7 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest25.00Strike Price0.00Turnover0.00%IV-167.67%PremiumJan 17, 2025Expiry Date15.66Intrinsic Value100Multiplier10DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma0.58Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Inogen Stock Discussion
Inogen Receives FDA 510(k) Clearance for SIMEOX 200 Airway Clearance Device
Monday, 30th December at 8:30 am
Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the SIMEOX 200 Airway Clearance Device, expanding the company's ability to market and meet the various needs of patients with chronic...
Second Quarter 2024 Financial Results
Second quarter total revenue increased 6.1% to $88.8 million from $83.6 million in the second quarter of 2023, primarily driven by higher demand and new customers in international and domestic business-to business sales, partially offset by lower direct-to-consumer sales and rental revenue.
Total gross margin was 48.1% in the second quarter of 2024 versus 40.7% in the comparative period in 2023. The increase was driven primarily by low...
An authorized Inogen dealer I work with said that Inogen G4s and G5s are failing more than half of the time forcing them to return them to Inogen. Inogen sells these devices directly to the public and I have to assume Innogen is not performing the additional testing that the dealer is doing or they would be finding the defective POCs before shipping. The specific defect mentioned is the device not recognizing the battery when AC power is disconnected. I would imagine that if the dealer is telling the truth (I have it in writing) there will be a recall on Inogen devices.
@KnowledgeIsPower @ChristinaLEA @Mark Padilla @Markus Williams
No comment yet